Find Pitolisant Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 903576-44-3, Ciproxidine, Bf 2649, Pitolisant hcl, Pitolisant (hydrochloride), Bf 2649 hydrochloride
Molecular Formula
C17H27Cl2NO
Molecular Weight
332.3  g/mol
InChI Key
XLFKECRRMPOAQS-UHFFFAOYSA-N
FDA UNII
YV33CH63HI

Pitolisant Hydrochloride
1 2D Structure

Pitolisant Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine;hydrochloride
2.1.2 InChI
InChI=1S/C17H26ClNO.ClH/c18-17-9-7-16(8-10-17)6-4-14-20-15-5-13-19-11-2-1-3-12-19;/h7-10H,1-6,11-15H2;1H
2.1.3 InChI Key
XLFKECRRMPOAQS-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CCN(CC1)CCCOCCCC2=CC=C(C=C2)Cl.Cl
2.2 Other Identifiers
2.2.1 UNII
YV33CH63HI
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 903576-44-3

2. Ciproxidine

3. Bf 2649

4. Pitolisant Hcl

5. Pitolisant (hydrochloride)

6. Bf 2649 Hydrochloride

7. Yv33ch63hi

8. Pitolisant Hydrochloride [usan]

9. 1-(3-(3-(4-chlorophenyl)propoxy)propyl)piperidine Hydrochloride

10. Piperidine, 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-, Hydrochloride

11. 903576-44-3 (hcl)

12. Wakix (tn)

13. Pitolisant Hydrochloride (usan)

14. 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine Hydrochloride

15. 1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine Hydrochloride

16. Piperidine, 1-(3-(3-(4-chlorophenyl)propoxy)propyl)-, Hydrochloride

17. Bf 2.649

18. Unii-yv33ch63hi

19. Schembl4591893

20. Bf-2649 Hydrochloride

21. Chembl4164059

22. Dtxsid50238098

23. Pitolisant;ciproxidine; Bf2649

24. Amy23423

25. Bcp16427

26. Ex-a1420

27. Hy-12199b

28. Pitolisant Hydrochloride [mi]

29. S5926

30. Akos024457784

31. Cs-1501

32. Sb17036

33. Pitolisant Hydrochloride [who-dd]

34. Ac-36017

35. As-72196

36. A3727

37. Pitolisant Hydrochloride [orange Book]

38. C77058

39. D11490

40. A900088

41. Q27895485

42. 1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine;hydrochloride

43. 1-(3-(3-(4-chlorophenyl)propoxy)propyl)piperidine Monohydrochloride

44. Piperidine, 1-(3-(3-(4-chlorophenyl)propoxy)propyl)-, Hydrochloride (1:1)

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 332.3 g/mol
Molecular Formula C17H27Cl2NO
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count8
Exact Mass331.1469699 g/mol
Monoisotopic Mass331.1469699 g/mol
Topological Polar Surface Area12.5 Ų
Heavy Atom Count21
Formal Charge0
Complexity235
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693506600,"product":"PITOLISANT HYDROCHLORIDE (QTY:10 GMS)(FOR TESTING PURPOSE ONLY)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR REDDY'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"SQUARE PHARMACEUTICALS PLC","customerCountry":"BANGLADESH","quantity":"0.01","actualQuantity":"10","unit":"GMS","unitRateFc":"27.4","totalValueFC":"277.1","currency":"USD","unitRateINR":2300,"date":"01-Sep-2023","totalValueINR":"23000","totalValueInUsd":"277.1","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"3637408","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693506600,"product":"PITOLISANT HYDROCHLORIDE(QTY:25 GMS)(FORTESTING PURPOSE ONLY)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR REDDY'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"SQUARE PHARMACEUTICALS PLC","customerCountry":"BANGLADESH","quantity":"0.03","actualQuantity":"25","unit":"GMS","unitRateFc":"27.4","totalValueFC":"674.6","currency":"USD","unitRateINR":2240,"date":"01-Sep-2023","totalValueINR":"56000","totalValueInUsd":"674.6","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"3637408","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1701023400,"product":"PITOLISANT HYDROCHLORIDE","address":"PLOT NO. 705, ADITYA TRADE CENTRE","city":"HYDERABAD ANDHRA PRADESH","supplier":"SHODHANA LABORATORIES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"ALI RAIF ILAC","customerCountry":"TURKEY","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"11000","totalValueFC":"32532.4","currency":"USD","unitRateINR":903000,"date":"27-Nov-2023","totalValueINR":"2709000","totalValueInUsd":"32532.4","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"5596633","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO. 705, ADITYA TRADE CENTRE, HYDERABAD ANDHRA PRADESH","customerAddress":""}]
01-Sep-2023
27-Nov-2023
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Wakix (pitolisant) is an oral H3 receptor antagonist/inverse agonist, small molecule drug. It is being evaluated for the treatment of idiopathic hypersomnia.


Lead Product(s): Pitolisant Hydrochloride

Therapeutic Area: Sleep Brand Name: Wakix

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 19, 2025

blank

01

ACS Fall 2025
Not Confirmed
ACS Fall 2025
Not Confirmed

Details : Wakix (pitolisant) is an oral H3 receptor antagonist/inverse agonist, small molecule drug. It is being evaluated for the treatment of idiopathic hypersomnia.

Product Name : Wakix

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

February 19, 2025

blank

Details:

Wakix (pitolisant) is an oral H3 receptor antagonist/inverse agonist, small molecule drug. It is being evaluated for the treatment of narcolepsy in pediatric patients 6 years of age and older.


Lead Product(s): Pitolisant Hydrochloride

Therapeutic Area: Sleep Brand Name: Wakix

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 24, 2024

blank

02

ACS Fall 2025
Not Confirmed
ACS Fall 2025
Not Confirmed

Details : Wakix (pitolisant) is an oral H3 receptor antagonist/inverse agonist, small molecule drug. It is being evaluated for the treatment of narcolepsy in pediatric patients 6 years of age and older.

Product Name : Wakix

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

June 24, 2024

blank

Details:

Wakix (pitolisant) is an oral histamine-3 (H3) receptor antagonist/inverse agonist, small molecule drug. It is being evaluated for the treatment of Prader-Willi syndrome.


Lead Product(s): Pitolisant Hydrochloride

Therapeutic Area: Genetic Disease Brand Name: Wakix

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 04, 2024

blank

03

ACS Fall 2025
Not Confirmed
ACS Fall 2025
Not Confirmed

Details : Wakix (pitolisant) is an oral histamine-3 (H3) receptor antagonist/inverse agonist, small molecule drug. It is being evaluated for the treatment of Prader-Willi syndrome.

Product Name : Wakix

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

March 04, 2024

blank

Details:

Wakix (pitolisant) is an oral histamine-3 (H3) receptor antagonist/inverse agonist, small molecule drug. It is being evaluated for the treatment of Prader-Willi syndrome.


Lead Product(s): Pitolisant Hydrochloride

Therapeutic Area: Genetic Disease Brand Name: Wakix

Study Phase: Phase IIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 20, 2024

blank

04

ACS Fall 2025
Not Confirmed
ACS Fall 2025
Not Confirmed

Details : Wakix (pitolisant) is an oral histamine-3 (H3) receptor antagonist/inverse agonist, small molecule drug. It is being evaluated for the treatment of Prader-Willi syndrome.

Product Name : Wakix

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

February 20, 2024

blank

Details:

Wakix (pitolisant hydrochloride) enhances the activity of histaminergic neurons and promotes wakefulness by blocking H3 autoreceptors and increasing the levels of histamine transmitters at the synapse and is being investigated for idiopathic hypersomnia.


Lead Product(s): Pitolisant Hydrochloride

Therapeutic Area: Sleep Brand Name: Wakix

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 13, 2023

blank

05

ACS Fall 2025
Not Confirmed
ACS Fall 2025
Not Confirmed

Details : Wakix (pitolisant hydrochloride) enhances the activity of histaminergic neurons and promotes wakefulness by blocking H3 autoreceptors and increasing the levels of histamine transmitters at the synapse and is being investigated for idiopathic hypersomnia.

Product Name : Wakix

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

October 13, 2023

blank

Details:

Wakix (pitolisant hydrochloride) enhances the activity of histaminergic neurons and promotes wakefulness by blocking H3 autoreceptors and increasing the levels of histamine transmitters at the synapse, which is used for Prader-Willi Syndrome.


Lead Product(s): Pitolisant Hydrochloride

Therapeutic Area: Genetic Disease Brand Name: Wakix

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 05, 2023

blank

06

ACS Fall 2025
Not Confirmed
ACS Fall 2025
Not Confirmed

Details : Wakix (pitolisant hydrochloride) enhances the activity of histaminergic neurons and promotes wakefulness by blocking H3 autoreceptors and increasing the levels of histamine transmitters at the synapse, which is used for Prader-Willi Syndrome.

Product Name : Wakix

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

October 05, 2023

blank

Details:

Wakix (pitolisant hydrochloride) enhances the activity of histaminergic neurons and promotes wakefulness by blocking H3 autoreceptors and increasing the levels of histamine transmitters at the synapse and is being investigated for Prader-Willi Syndrome.


Lead Product(s): Pitolisant Hydrochloride

Therapeutic Area: Genetic Disease Brand Name: Wakix

Study Phase: Phase IIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 20, 2023

blank

07

ACS Fall 2025
Not Confirmed
ACS Fall 2025
Not Confirmed

Details : Wakix (pitolisant hydrochloride) enhances the activity of histaminergic neurons and promotes wakefulness by blocking H3 autoreceptors and increasing the levels of histamine transmitters at the synapse and is being investigated for Prader-Willi Syndrome.

Product Name : Wakix

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

July 20, 2023

blank

Details:

Wakix (pitolisant HCl) is a 5-HT3 receptor Inhibitor Small molecule drug candidate, which is currently being evaluated for the treatment of adult patients with myotonic dystrophy type 1.


Lead Product(s): Pitolisant Hydrochloride

Therapeutic Area: Neurology Brand Name: Wakix

Study Phase: Phase IIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 12, 2023

blank

08

ACS Fall 2025
Not Confirmed
ACS Fall 2025
Not Confirmed

Details : Wakix (pitolisant HCl) is a 5-HT3 receptor Inhibitor Small molecule drug candidate, which is currently being evaluated for the treatment of adult patients with myotonic dystrophy type 1.

Product Name : Wakix

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

July 12, 2023

blank

Details:

Wakix (pitolisant hydrochloride) enhances the activity of histaminergic neurons and promotes wakefulness by blocking H3 autoreceptors and increasing the levels of histamine transmitters at the synapse and is being investigated for idiopathic hypersomnia.


Lead Product(s): Pitolisant Hydrochloride

Therapeutic Area: Sleep Brand Name: Wakix

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 09, 2023

blank

09

ACS Fall 2025
Not Confirmed
ACS Fall 2025
Not Confirmed

Details : Wakix (pitolisant hydrochloride) enhances the activity of histaminergic neurons and promotes wakefulness by blocking H3 autoreceptors and increasing the levels of histamine transmitters at the synapse and is being investigated for idiopathic hypersomnia.

Product Name : Wakix

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

July 09, 2023

blank

Details:

Wakix (pitolisant hydrochloride) enhances the activity of histaminergic neurons and promotes wakefulness by blocking H3 autoreceptors and increasing the levels of histamine transmitters at the synapse, which is used for Prader-Willi Syndrome.


Lead Product(s): Pitolisant Hydrochloride

Therapeutic Area: Genetic Disease Brand Name: Wakix

Study Phase: Phase IIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 06, 2023

blank

10

ACS Fall 2025
Not Confirmed
ACS Fall 2025
Not Confirmed

Details : Wakix (pitolisant hydrochloride) enhances the activity of histaminergic neurons and promotes wakefulness by blocking H3 autoreceptors and increasing the levels of histamine transmitters at the synapse, which is used for Prader-Willi Syndrome.

Product Name : Wakix

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

June 06, 2023

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

HARMONY

U.S.A
ACS Fall 2025
Not Confirmed
arrow

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

Brand Name : WAKIX

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 4.45MG BASE

Approval Date : 2019-08-14

Application Number : 211150

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

HARMONY

U.S.A
ACS Fall 2025
Not Confirmed
arrow

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

Brand Name : WAKIX

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 17.8MG BASE

Approval Date : 2019-08-14

Application Number : 211150

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

ACS Fall 2025
Not Confirmed
arrow
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT

Brand Name : PITOLISANT

Dosage Form : TABLET; FILM COATED

Dosage Strength : 4.45MG

Approval Date :

Application Number : 218873

RX/OTC/DISCN :

RLD :

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

US Patent Number : 8354430

Drug Substance Claim :

Drug Product Claim :

Application Number : 211150

Patent Use Code : U-1102

Delist Requested :

Patent Use Description : METHOD OF TREATING CAT...

Patent Expiration Date : 2026-02-06

blank

02

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

US Patent Number : 8486947

Drug Substance Claim :

Drug Product Claim :

Application Number : 211150

Patent Use Code : U-1101

Delist Requested :

Patent Use Description : METHOD OF TREATING EXC...

Patent Expiration Date : 2029-09-26

blank

03

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

US Patent Number : 8486947

Drug Substance Claim :

Drug Product Claim :

Application Number : 211150

Patent Use Code : U-1102

Delist Requested :

Patent Use Description : METHOD OF TREATING CAT...

Patent Expiration Date : 2029-09-26

blank

04

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

US Patent Number : 8486947

Drug Substance Claim :

Drug Product Claim :

Application Number : 211150

Patent Use Code : U-1101

Delist Requested :

Patent Use Description : METHOD OF TREATING EXC...

Patent Expiration Date : 2029-09-26

blank

05

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

US Patent Number : 8354430

Drug Substance Claim :

Drug Product Claim :

Application Number : 211150

Patent Use Code : U-1101

Delist Requested :

Patent Use Description : METHOD OF TREATING EXC...

Patent Expiration Date : 2026-02-06

blank

06

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

US Patent Number : 8354430

Drug Substance Claim :

Drug Product Claim :

Application Number : 211150

Patent Use Code : U-1101

Delist Requested :

Patent Use Description : METHOD OF TREATING EXC...

Patent Expiration Date : 2026-02-06

blank

07

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

US Patent Number : 8207197

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211150

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-03-07

blank

08

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

US Patent Number : 8207197

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211150

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-03-07

blank

09

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

US Patent Number : 8486947

Drug Substance Claim :

Drug Product Claim :

Application Number : 211150

Patent Use Code : U-1102

Delist Requested :

Patent Use Description : METHOD OF TREATING CAT...

Patent Expiration Date : 2029-09-26

blank

10

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

US Patent Number : 8354430

Drug Substance Claim :

Drug Product Claim :

Application Number : 211150

Patent Use Code : U-1102

Delist Requested :

Patent Use Description : METHOD OF TREATING CAT...

Patent Expiration Date : 2026-02-06

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

US Exclusivities

read-more
read-more

01

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2027-06-21

Application Number : 211150

Product Number : 1

Exclusivity Details :

blank

02

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

Exclusivity Code : ODE-255

Exclusivity Expiration Date : 2026-08-14

Application Number : 211150

Product Number : 1

Exclusivity Details :

blank

03

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

Exclusivity Code : ODE-331

Exclusivity Expiration Date : 2027-10-13

Application Number : 211150

Product Number : 1

Exclusivity Details :

blank

04

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

Exclusivity Code : ODE-489

Exclusivity Expiration Date : 2031-06-21

Application Number : 211150

Product Number : 1

Exclusivity Details :

blank

05

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2027-06-21

Application Number : 211150

Product Number : 2

Exclusivity Details :

blank

06

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

Exclusivity Code : ODE-255

Exclusivity Expiration Date : 2026-08-14

Application Number : 211150

Product Number : 2

Exclusivity Details :

blank

07

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

Exclusivity Code : ODE-331

Exclusivity Expiration Date : 2027-10-13

Application Number : 211150

Product Number : 2

Exclusivity Details :

blank

08

arrow
ACS Fall 2025
Not Confirmed

HARMONY

U.S.A
arrow
ACS Fall 2025
Not Confirmed

PITOLISANT HYDROCHLORIDE

Exclusivity Code : ODE-489

Exclusivity Expiration Date : 2031-06-21

Application Number : 211150

Product Number : 2

Exclusivity Details :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 903576-44-3 / Pitolisant Hydrochloride API manufacturers, exporters & distributors?

Pitolisant Hydrochloride manufacturers, exporters & distributors 1

97

PharmaCompass offers a list of Pitolisant Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pitolisant Hydrochloride manufacturer or Pitolisant Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pitolisant Hydrochloride manufacturer or Pitolisant Hydrochloride supplier.

PharmaCompass also assists you with knowing the Pitolisant Hydrochloride API Price utilized in the formulation of products. Pitolisant Hydrochloride API Price is not always fixed or binding as the Pitolisant Hydrochloride Price is obtained through a variety of data sources. The Pitolisant Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Pitolisant Hydrochloride

Synonyms

903576-44-3, Ciproxidine, Bf 2649, Pitolisant hcl, Pitolisant (hydrochloride), Bf 2649 hydrochloride

Cas Number

903576-44-3

Unique Ingredient Identifier (UNII)

YV33CH63HI

Pitolisant Hydrochloride Manufacturers

A Pitolisant Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pitolisant Hydrochloride, including repackagers and relabelers. The FDA regulates Pitolisant Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pitolisant Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Pitolisant Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Pitolisant Hydrochloride Suppliers

A Pitolisant Hydrochloride supplier is an individual or a company that provides Pitolisant Hydrochloride active pharmaceutical ingredient (API) or Pitolisant Hydrochloride finished formulations upon request. The Pitolisant Hydrochloride suppliers may include Pitolisant Hydrochloride API manufacturers, exporters, distributors and traders.

click here to find a list of Pitolisant Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Pitolisant Hydrochloride USDMF

A Pitolisant Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Pitolisant Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Pitolisant Hydrochloride DMFs exist exist since differing nations have different regulations, such as Pitolisant Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Pitolisant Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Pitolisant Hydrochloride USDMF includes data on Pitolisant Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pitolisant Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Pitolisant Hydrochloride suppliers with USDMF on PharmaCompass.

Pitolisant Hydrochloride WC

A Pitolisant Hydrochloride written confirmation (Pitolisant Hydrochloride WC) is an official document issued by a regulatory agency to a Pitolisant Hydrochloride manufacturer, verifying that the manufacturing facility of a Pitolisant Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pitolisant Hydrochloride APIs or Pitolisant Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Pitolisant Hydrochloride WC (written confirmation) as part of the regulatory process.

click here to find a list of Pitolisant Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.

Pitolisant Hydrochloride NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pitolisant Hydrochloride as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Pitolisant Hydrochloride API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Pitolisant Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Pitolisant Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pitolisant Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Pitolisant Hydrochloride suppliers with NDC on PharmaCompass.

Pitolisant Hydrochloride GMP

Pitolisant Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Pitolisant Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pitolisant Hydrochloride GMP manufacturer or Pitolisant Hydrochloride GMP API supplier for your needs.

Pitolisant Hydrochloride CoA

A Pitolisant Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Pitolisant Hydrochloride's compliance with Pitolisant Hydrochloride specifications and serves as a tool for batch-level quality control.

Pitolisant Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Pitolisant Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Pitolisant Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Pitolisant Hydrochloride EP), Pitolisant Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pitolisant Hydrochloride USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty